Having served as President of the USP Convention during the 2015-2020 cycle, Dr. Jesse Goodman will help guide USP as it begins its third century of promoting and protecting public health. In his role as Medical Sciences Trustee on USP’s board, Dr. Goodman will apply his knowledge of USP along with his personal and professional experience as the organization rises to the challenges of the global supply chain and helping to ensure ongoing access to quality medicines for people around the world.
His day-to-day experiences as a practicing clinician coupled with the knowledge that he gained during years with FDA have given Dr. Goodman an appreciation for the need for balanced and collaborative approaches to regulations and what that could do to keep our drug and food supply as safe and effective as possible.
Dr. Goodman is the Director of the Center on Medical Product Access, Safety and Stewardship and attending physician at Georgetown University and DC Veterans Administration Hospitals. Until 2014, Dr. Goodman was FDA’s Chief Scientist, leading crosscutting scientific efforts, including public health preparedness and medical countermeasures. Prior to that, Dr. Goodman directed FDA’s Center for Biologics Evaluation and Research, supporting innovative regulatory approaches to vaccines and other biologics and spearheading unique public–private efforts to address public health challenges. As Senior Advisor to the Commissioner, he initiated the first U.S. Task Force on Antimicrobial Resistance. Having served on the World Health Organization’s Ebola Vaccine Working Group, Dr. Goodman helped develop the Global Vaccine Action Plan. He is currently on the Centers for Disease Control and Prevention’s Board of Scientific Counselors (Infectious Diseases).
A Harvard graduate, Dr. Goodman received his M.D. from Albert Einstein College of Medicine and completed postdoctoral training at the University of Pennsylvania and UCLA, where he was Chief Resident. He has been elected to the Institute of Medicine of the National Academy of Sciences.
- University of Minnesota: Professor of Medicine and Chief of Infectious Diseases
- U.S. Food and Drug Administration: Director, Center for Biologics Evaluation and Research (CBER), Chief Scientist and Deputy Commissioner for Science and Public Health
- Georgetown University: Professor of Medicine and Infectious Diseases
- Albert Einstein College of Medicine, M.D.
- University of Minnesota, M.P.H.
- Harvard College, B.A.
Awards, Recognition, Admissions:
- National Academy of Medicine of the National Academy of Sciences
- HHS Secretary’s Awards for West Nile Virus Response, for Tissue Safety and for Innovative Response to an Influenza Vaccine Supply Crisis
A Few Favorite Professional Achievements:
- Our laboratory team at the University of Minnesota isolated and characterized Anaplasma phagocytophilum, the cause of a then-new infectious disease, Granulocytic Anaplasmosis.
- Started and co-chaired the first U.S. Task Force on Antimicrobial Resistance and co-authored its governmental National Action Plan.
- Developed a public-private partnership of U.S. federal agencies and the blood and diagnostic industries to rapidly develop and implement national testing of blood and organ donors for West Nile Virus, to prevent its transmission through transfusion and transplantation.
- Partnered in developing FDA’s and HHS’s medical countermeasure initiatives and enterprises and FDA’s emergency use authorities and helped lead U.S. responses to various public health emergencies, including the 2009 H1N1 pandemic.
- Day-to-day care of patients and teaching medicine to students, residents and Fellows.